Patents by Inventor Ellen Santangelo

Ellen Santangelo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240316059
    Abstract: The invention provides compounds of formula (I), that are peptidase enhanced cytotoxics. The invention further provides pharmaceutical compositions comprising the compounds, and the use of the compounds or pharmaceutical compositions as a medicament, particularly for use in the treatment or prophylaxis of cancers such as multiple myeloma, osteosarcoma, breast cancer, lung cancer, ovarian cancer, leukaemia and lymphoma.
    Type: Application
    Filed: June 20, 2022
    Publication date: September 26, 2024
    Applicant: Oncopeptides AB
    Inventors: Antonio BERMEJO GOMEZ, Praveen KUMAR CHINTHAKINDI, Charles DEMMER, Katarina FARNEGARDH, Mathias FARNEGARDH, Fredrik LEHMANN, Ellen SANTANGELO
  • Patent number: 8188101
    Abstract: Dihydropyridopyrimidine compounds of formula (Ia) and therapeutically acceptable salts thereof, wherein R1, R2 and Z are as defined in the specification; processes for making them and methods for using them in the treatment of A?-related pathologies.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: May 29, 2012
    Assignee: AstraZeneca AB
    Inventors: Rickard Forsblom, Kim Paulsen, Didier Rotticci, Ellen Santangelo, Magnus Waldman
  • Publication number: 20100130495
    Abstract: The present invention relates to novel compounds of formula I and therapeutically acceptable salts thereof, their pharmaceutical compositions, processes for making them and their use as therapeutic methods for treatment and/or prevention of various diseases.
    Type: Application
    Filed: November 6, 2009
    Publication date: May 27, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Rickard FORSBLOM, Kim PAULSEN, Didier ROTTICCI, Ellen SANTANGELO, Magnus WALDMAN